Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: RITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53 abnormalmyeloma cells independently of the p53 pathway

Figure 1

Myeloma cells were heterogeneously sensitive to RITA. A,D. LD50 values for RITA (A) and nutlin3a (D) of HMCLs were plotted against the TP53 status of HMCLs. wt: wild type, m: mutated, trunc: truncated, KO: deleted. Cells (100,000/0.2 ml) from 32 HMCLs were incubated for 72 h with serial dilutions of RITA (20 μM to 1 nM) or nutlin3a (20 μM to 1.25 μM), and cell death was assessed using flow cytometry after APO2.7 staining (Cell Quest software, FACSCalibur). The LD50 was defined as the concentration that killed 50% of cells (mean of 3 experiments). wt: wild-type, m:mutated, trun: truncated, KO: deleted. B,E. Contingency analysis of the sensitivity of HMCLs to RITA (B) or nutlin3a (E) with respect to TP53 status. C,F. The LD50 values for RITA (C) and nutlin3a (F) of HMCLs were plotted against the 14q32 status of the HMCLs. Circle and triangle symbols represent TP53 wt and TP53 Abnormal HMCLs, respectively. G. Apoptosis induced by RITA and nutlin3a in normal PBMCs. PBMCs were incubated for 3 days in RPMI1640 medium containing 5% FCS with serial concentrations of RITA or nutlin3a. Data represent the mean ± SE of 3 independent donors.

Back to article page